60 cases of histologically verified pinealoma of the two-cell-pattern type (the so-called germinoma) experienced from 1962 to 1979 were submitted to direct surgery (by occipital transtentorial approach or infratentorial supracerebellar approach in case of tumors in the pineal region and subfrontal approach in cases of suprasellar tumors) and postoperative irradiation. Locations of tumors were 32 in the pineal region, 20 in the suprasellar region, and 8 in other areas. There was no operative mortality. The postoperative survival rates (the observed survival rates) of these cases were as follows: the 1-year survival rate (1 YSR) was 94.8%, the 5-year survival rate (5 YSR) was 74.8% and 10-year survival rate (10 YSR) was 69.3%. As for pinealomas in the pineal region, 1 YSR was 93.5%, 5 YSR was 64.7% and 10 YSR was 60.1 %; for tumors in the suprasellar region, 1 YSR was 100%, 5 YSR was 100% and 10 YSR was 92.3%. In cases aged from 15 years up, 1 YSR was 93.7%, 5 YSR was 65.0% and 10 YSR was 60.2%, and in cases under 15 years (children), 1 YSR was 95.1%, 5 YSR was 86.9% and 10 YSR was 86.9%. Thus, the results were much better in suprasellar germinoma cases than in pineal cases and in children than in adolescents and adults. Suprasellar germinoma cases under 15 years showed 100%in 1 YSR, 5 YSR and 10 YSR. The reason for this is probably that surgical removal of tumors or reduction of the bulk of tumors may be easier or more extensive in suprasellar germinomas than in pineal germinomas. Among these 60 cases, 2 died of recurrence of tumor, 3 died of dissemination metastases in the cerebrospinal fluid space and the other 11 died of other diseases or due to unknown cause. Besides these 60 cases, 10 cases of probable pinealomas (germinomas) were treated by irradiation without direct surgery. Among these, 1 case died 3 years and 1 month later and 1 case had recurrence and was irradiated again. Most of these cases were experienced in the past 2 years and the follow-up was not long enough. All these cases had rather small tumors, single or multiple. The histogenesis of the tumor and the causes of its radiosensitivity are discussed.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.